A Cancer-causing Gene May Benefit Patients During Chemotherapy
CHOP researchers report that a well-known gene that normally drives cancer could potentially benefit cancer patients if used in combination with chemotherapy.
Cancer is a multifactorial disease that frequently arises from complex interactions between genetic, developmental and environmental factors. A growing knowledge of cancer genetics and genomics has helped to improve cancer risk assessment, better predict disease progression, assist with treatment selection, and aid in the development of new targeted cancer therapies.
CHOP researchers report that a well-known gene that normally drives cancer could potentially benefit cancer patients if used in combination with chemotherapy.